PACS Group, Inc. november 6, 2024 Join Investigation Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com PACS Group Is Being Investigated for Potential Securities Law Violations – Contact Kaplan Fox & Kilsheimer LLP Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an PACS investor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. PACS purports to be a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. On November 4, 2024 Hindenburg Research published a report entitled, “PACS Group: How To Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers” (the “Hindenburg Report”). The Hindenburg Report, which was the product of an investigation that spanned five months and involved interviews with numerous former employees, alleges PACS’ “turnaround” formula for transforming poorly performing skilled nursing facilities “largely boils down to systematically scamming taxpayer-funded healthcare programs” and that “PACS abused a COVID-era waiver, inappropriately accessing skilled care Medicare benefits for thousands of patients across its national portfolio of facilities.” The Hindenburg Report further alleges that “the scheme drove more than 100% of PACS’ operating and net income from 2020 – 2023, enabling PACS to IPO in early 2024 with the illusion of legitimate growth and profitability.” Following this news, the price of PACS stock fell $11.93 per share, nearly 28%, to close at $31.01 per share on November 4, 2024. Subsequently, the stock price has continued to plummet, closing at $18.09 on November 6, 2024, representing a decline of over 57% since the Hindenburg Report was published. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this investigation, please contact: Jeffrey P. CampisiKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003 pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us PACS Group, Inc. See the Case WM Technology See the Case Humacyte, Inc. See the Case Acadia Healthcare Company, Inc. See the Case Edwards Lifesciences Corporation See the Case United Parcel Service, Inc. See the Case Elanco Animal Health Incorporated See the Case Iris Energy Ltd See the Case Toronto-Dominion Bank See the Case Fluence Energy, Inc. See the Case Light & Wonder, Inc. See the Case Paragon 28, Inc. See the Case
